We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$225M
AUM Growth
+$15.9M
Cap. Flow
+$3.44M
Cap. Flow %
1.53%
Top 10 Hldgs %
39.42%
Holding
58
New
1
Increased
18
Reduced
19
Closed
1

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.23M
2
GLW icon
Corning
GLW
+$1.7M
3
EMR icon
Emerson Electric
EMR
+$1.57M
4
MIDD icon
Middleby
MIDD
+$1.48M
5
RVTY icon
Revvity
RVTY
+$1.07M

Sector Composition

Rank Sector Weight
1 Technology 28.91%
2 Healthcare 25.59%
3 Industrials 17.79%
4 Materials 15.62%
5 Financials 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLM icon
1
Martin Marietta Materials
MLM
$31.5B
$10.8M 4.8%
23,383
+75
+0.3% +$29.6K
SPGI icon
2
S&P Global
SPGI
$121B
$9.9M 4.4%
24,696
-250
-1% -$91.3K
LIN icon
3
Linde
LIN
$221B
$9.62M 4.27%
25,245
ROP icon
4
Roper Technologies
ROP
$38.8B
$9.19M 4.08%
19,111
-550
-3% -$249K
BDX icon
5
Becton Dickinson
BDX
$45.6B
$8.55M 3.8%
32,370
+8,790
+37% +$2.23M
DHR icon
6
Danaher
DHR
$137B
$8.42M 3.74%
39,589
+902
+2% +$191K
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.1T
$8.3M 3.69%
24,350
HEI icon
8
HEICO Corp
HEI
$49.8B
$8.08M 3.59%
45,666
ADSK icon
9
Autodesk
ADSK
$49.5B
$8.07M 3.59%
39,450
+3,100
+9% +$620K
TMO icon
10
Thermo Fisher Scientific
TMO
$213B
$7.82M 3.47%
14,992
+25
+0.2% +$13.5K
PAYX icon
11
Paychex
PAYX
$41.6B
$7.22M 3.21%
64,575
+200
+0.3% +$21.9K
IT icon
12
Gartner
IT
$10.1B
$7.21M 3.2%
20,580
TECH icon
13
Bio-Techne
TECH
$11.2B
$7.19M 3.2%
88,135
-1,300
-1% -$104K
EW icon
14
Edwards Lifesciences
EW
$49.6B
$7.08M 3.14%
75,025
STE icon
15
Steris
STE
$22.3B
$6.68M 2.97%
29,705
-3,600
-11% -$720K
RVTY icon
16
Revvity
RVTY
$12.6B
$6.43M 2.86%
54,118
+8,700
+19% +$1.07M
WTS icon
17
Watts Water Technologies
WTS
$11.5B
$6.22M 2.76%
33,845
MKC icon
18
McCormick & Company Non-Voting
MKC
$13.7B
$5.9M 2.62%
67,584
+500
+0.7% +$44.2K
LII icon
19
Lennox International
LII
$14.4B
$5.76M 2.56%
17,660
-2,390
-12% -$675K
SHW icon
20
Sherwin-Williams
SHW
$82.7B
$5.75M 2.55%
21,650
+750
+4% +$177K
ANSS
21
DELISTED
Ansys
ANSS
$5.68M 2.52%
17,190
MIDD icon
22
Middleby
MIDD
$6.04B
$4.97M 2.21%
33,604
+10,475
+45% +$1.48M
EMR icon
23
Emerson Electric
EMR
$83.9B
$4.95M 2.2%
54,743
+18,600
+51% +$1.57M
FISV
24
Fiserv Inc
FISV
$28.8B
$4.86M 2.16%
38,547
-100
-0.3% -$11.8K
APH icon
25
Amphenol
APH
$198B
$4.67M 2.08%
109,982
+3,800
+4% +$148K

Similar funds

Stone Run Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Stone Run Capital held 58 positions worth $225M, up 7.6% from $209M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.4%. Stone Run Capital opened 1 new position and exited 1, leaving the 58-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Stone Run Capital's largest Q2 2023 buy was Charles River Laboratories: 983 shares worth $207K.
  • Stone Run Capital added most to Becton Dickinson in Q2 2023, an estimated $2.23M increase.
  • Stone Run Capital's biggest Q2 2023 reduction was International Flavors & Fragrances, cutting an estimated $3.14M.
  • Stone Run Capital fully exited Canadian Pacific Kansas City in Q2 2023, selling an estimated $259K.
  • Stone Run Capital's ten largest holdings make up 39% of its $225M portfolio in Q2 2023.
  • Stone Run Capital opened 1 new position and closed 1 in Q2 2023.
  • Stone Run Capital's portfolio value rose 7.6% quarter-over-quarter to $225M.

Based on Stone Run Capital's 13F filing for Q2 2023, filed 14 Aug 2023.